BioMarin Pharmaceutical Inc (BMRN) stock
BMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/3093% above fair value
$58.51+0.52 (+0.90%)
Close on Nov 17, 2026Market cap $11.33BP/E 154.0Yield –
BioMarin Pharmaceutical total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
BioMarin Pharmaceutical's total debt was $4.19B at Jun 30, 2026. For fiscal 2025 it was $597.18M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $597.18M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.19B | – |
| Q4 FY2025 | Dec 31, 2025 | $597.18M | – |
See a number that looks wrong?